The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Multi-target approach for natural products in inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
Morphy, R., & Rankovic, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,209
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
McGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
BALOGUN, E., HOQUE, M., GONG, P., KILLEEN, E., GREEN, C. J., FORESTI, R., ALAM, J., & MOTTERLINI, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,036
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers
Hollman, P., de Vries, J., van Leeuwen, S., Mengelers, M., & Katan, M. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1276 · Cited by 959
Curcumin—From Molecule to Biological Function
Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107724 · Cited by 904
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. J., Peggie, M. W., Zibrova, D., Green, K. A., Mustard, K. J., et al. (2012) · Science · doi:10.1126/science.1215327 · Cited by 739
From magic bullets to designed multiple ligands
Morphy, R., Kay, C., & Rankovic, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 729
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 688
Ungvari, Z., Bagi, Z., Feher, A., Recchia, F. A., Sonntag, W. E., Pearson, K., de Cabo, R., & Csiszar, A. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00260.2010 · Cited by 568
Lin, Y., & Lin, J. (1997) · PubMed · Cited by 539
Tissue Distribution of Quercetin in Rats and Pigs
de Boer, V. C. J., Dihal, A. A., van der Woude, H., Arts, I. C. W., Wolffram, S., Alink, G. M., Rietjens, I. M. C. M., Keijer, J., & Hollman, P. C. H. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.7.1718 · Cited by 524
Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo
Nam, S., Smith, D. M., & Dou, Q. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004209200 · Cited by 504
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
Smith, W. L., Urade, Y., & Jakobsson, P.-J. (2011) · Chemical Reviews · doi:10.1021/cr2002992 · Cited by 503
Garcea, G., Berry, D. P., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., & Gescher, A. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.120.14.1 · Cited by 494
Shifting from the single to the multitarget paradigm in drug discovery
Medina-Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.008 · Cited by 483
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 463
Lin, Y.-L., & Lin, J.-K. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.465 · Cited by 463
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé-Carneiro, J., Larrosa, M., González-Sarrías, A., Tomás-Barberán, F., García-Conesa, M., & Espín, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 449
Hong, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh165 · Cited by 432
Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax induction
Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T., & Sa, G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02292-5 · Cited by 429
Puissant, A., Robert, G., Fenouille, N., Luciano, F., Cassuto, J.-P., Raynaud, S., & Auberger, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3537 · Cited by 374
Anti-inflammatory effects of aspirin and sodium salicylate
Amann, R., & Peskar, B. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01828-9 · Cited by 372
Unveiling the role of network and systems biology in drug discovery
Pujol, A., Mosca, R., Farrés, J., & Aloy, P. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.006 · Cited by 346
Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
Park, C. H., Chang, J. Y., Hahm, E. R., Park, S., Kim, H.-K., & Yang, C. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.151 · Cited by 337
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Bender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327
R. Neves, A., Lucio, M., L.C. Lima, J., & Reis, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799945085 · Cited by 313
Curcumin and its analogues: Potential anticancer agents
Agrawal, D. K., & Mishra, P. K. (2010) · Medicinal Research Reviews · doi:10.1002/med.20188 · Cited by 312
Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data
Abdel-Tawab, M., Werz, O., & Schubert-Zsilavecz, M. (2011) · Clinical Pharmacokinetics · doi:10.2165/11586800-000000000-00000 · Cited by 311
Self-citationCasagrande, F., & Darbon, J.-M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00583-4 · Cited by 303
Natural-product-derived fragments for fragment-based ligand discovery
Over, B., Wetzel, S., Grütter, C., Nakai, Y., Renner, S., Rauh, D., & Waldmann, H. (2013) · Nature Chemistry · doi:10.1038/nchem.1506 · Cited by 300
Natarajan, C., & Bright, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6506 · Cited by 288
Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287
Schwenger, P., Bellosta, P., Vietor, I., Basilico, C., Skolnik, E. Y., & Vilček, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2869 · Cited by 274
Hong, J., Smith, T. J., Ho, C.-T., August, D. A., & Yang, C. S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00767-5 · Cited by 261
Telomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea Catechins
Naasani, I., Seimiya, H., & Tsuruo, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9075 · Cited by 238
Liang, Y.-C., Lin-Shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19991001)75:1<1::aid-jcb1>3.0.co;2-n · Cited by 222
Fragments, network biology and designing multiple ligands
Morphy, R., & Rankovic, Z. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.12.006 · Cited by 204
Aziz, M. H., Nihal, M., Fu, V. X., Jarrard, D. F., & Ahmad, N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0526 · Cited by 201
Lee, K. W., Kang, N. J., Heo, Y.-S., Rogozin, E. A., Pugliese, A., Hwang, M. K., Bowden, G. T., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3140 · Cited by 194
Flavonol Activation Defines an Unanticipated Ligand-Binding Site in the Kinase-RNase Domain of IRE1
Wiseman, R. L., Zhang, Y., Lee, K. P. K., Harding, H. P., Haynes, C. M., Price, J., Sicheri, F., & Ron, D. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.001 · Cited by 190
Cellular and molecular effects of resveratrol in health and disease
Yu, W., Fu, Y., & Wang, W. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23431 · Cited by 182
Cronstein, B. N., Montesinos, M. C., & Weissmann, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6377 · Cited by 182
Pillinger, M. H., Capodici, C., Rosenthal, P., Kheterpal, N., Hanft, S., Philips, M. R., & Weissmann, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14540 · Cited by 181
Synergistic action of pro-inflammatory agents: cellular and molecular aspects
Paludan, S. R. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.18 · Cited by 177
Inhibition of 5-Lipoxygenase Product Synthesis by Natural Compounds of Plant Origin
Werz, O. (2007) · Planta Medica · doi:10.1055/s-2007-990242 · Cited by 176
Self-citationCelotti, F., & Laufer, S. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0784 · Cited by 171
Effects of Quercetin and EGCG on Mitochondrial Biogenesis and Immunity
Nieman, D. C., Henson, D. A., Maxwell, K. R., Williams, A. S., McAnulty, S. R., Jin, F., Shanely, R. A., & Lines, T. C. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318199491f · Cited by 167
Koeberle, A., Siemoneit, U., Bühring, U., Northoff, H., Laufer, S., Albrecht, W., & Werz, O. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139444 · Cited by 164
Self-citationKasinski, A. L., Du, Y., Thomas, S. L., Zhao, J., Sun, S.-Y., Khuri, F. R., Wang, C.-Y., Shoji, M., Sun, A., Snyder, J. P., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046201 · Cited by 159
High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines
Dumlao, D. S., Buczynski, M. W., Norris, P. C., Harkewicz, R., & Dennis, E. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.005 · Cited by 158
Renal Effects of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors
Cheng, H., & Harris, R. C. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764922 · Cited by 152
Mitchell, J. A., Saunders, M., Barnes, P. J., Newton, R., & Belvisi, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.907 · Cited by 148
Inhibitors of the Arachidonic Acid Cascade: Interfering with Multiple Pathways
Meirer, K., Steinhilber, D., & Proschak, E. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12134 · Cited by 139
Yang, F., Oz, H. S., Barve, S. S., de Villiers, W. J. S., McClain, C. J., & Varilek, G. W. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12615-6 · Cited by 137
The Antifolate Activity of Tea Catechins
Navarro-Perán, E., Cabezas‐Herrera, J., Garcı́a-Cánovas, F., Durrant, M. C., THORNELEY, R. N. F., & Rodríguez‐López, J. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3469 · Cited by 136
Koeberle, A., Northoff, H., & Werz, O. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0290 · Cited by 122
Self-citationQuercetin inhibits a large panel of kinases implicated in cancer cell biology
Kiss (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.890 · Cited by 116
Raynauld, J., Martel‐Pelletier, J., Haraoui, B. P., Choquette, D., Dorais, M., Wildi, L. M., Abram, F., & Pelletier, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146407 · Cited by 113
Koeberle, A., & Werz, O. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789578178 · Cited by 110
Self-citationBerger, S. J., Gupta, S., Belfi, C. A., Gosky, D. M., & Mukhtar, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5736 · Cited by 107
A pharmacological organization of G protein–coupled receptors
Lin, H., Sassano, M. F., Roth, B. L., & Shoichet, B. K. (2013) · Nature Methods · doi:10.1038/nmeth.2324 · Cited by 106
Bustanji, Y. K., Taha, M. O., Almasri, I. M., Al-Ghussein, M. A. S., Mohammad, M. K., & AlKhatib, H. S. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360802364377 · Cited by 104
Complex phenotypic assays in high-throughput screening
Clemons, P. A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.002 · Cited by 102
Peet, G. W., & Li, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32655 · Cited by 102
Ulrich, S., Loitsch, S. M., Rau, O., von Knethen, A., Brüne, B., Schubert-Zsilavecz, M., & Stein, J. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2777 · Cited by 95
Koeberle, A., Shindou, H., Koeberle, S. C., Laufer, S., Shimizu, T., & Werz, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216182110 · Cited by 91
Self-citationMicrosomal prostaglandin E synthase‐1 and 5‐lipoxygenase: potential drug targets in cancer
Rådmark, O., & Samuelsson, B. O. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02246.x · Cited by 90
Fischer, L., Hörnig, M., Pergola, C., Meindl, N., Franke, L., Tanrikulu, Y., Dodt, G., Schneider, G., Steinhilber, D., & Werz, O. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707416 · Cited by 78
Self-citationLi, Y., Ferrante, A., Poulos, A., & Harvey, D. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118585 · Cited by 74
Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Costantino, L., & Barlocco, D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801215883 · Cited by 72
Inhibitory Effect of Green Tea Polyphenols on Membrane-Type 1 Matrix Metalloproteinase, MT1-MMP1)
Oku, N., Matsukawa, M., Yamakawa, S., Asai, T., Yahara, S., Hashimoto, F., & Akizawa, T. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1235 · Cited by 70
Hsieh, T., Wong, C. S. F., Bennett, D. J., & WU, J. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25930 · Cited by 69
Koeberle, A., Muñóz, E., Appendino, G., Minassi, A., Pace, S., Rossi, A., Weinigel, C., Barz, D., Sautebin, L., Caprioglio, D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500308c · Cited by 68
Self-citationInhibition of cyclic AMP-dependent protein kinase by curcumin
Hasmeda, M., & Polya, G. M. (1996) · Phytochemistry · doi:10.1016/0031-9422(96)00091-x · Cited by 67
A series of case studies: practical methodology for identifying antinociceptive multi-target drugs
Pang, M.-H., Kim, Y., Jung, K. W., Cho, S., & Lee, D. H. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.003 · Cited by 65
Suzuki, K., & Koike, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.164 · Cited by 62
Fung, S.-T., Ho, C. K.-C., Choi, S. W., Chung, W.-Y., & Benzie, I. F. F. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004370 · Cited by 55
Iwasaki, M., Inoue, M., Sasazuki, S., Miura, T., Sawada, N., Yamaji, T., Shimazu, T., Willett, W. C., & Tsugane, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0916-x · Cited by 52
Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E2 synthase-1
Koeberle, A., Bauer, J., Verhoff, M., Hoffmann, M., Northoff, H., & Werz, O. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.005 · Cited by 50
Self-citationAnnabi, B., Lord‐Dufour, S., Vézina, A., & Béliveau, R. (2012) · Drug Target Insights · doi:10.4137/dti.s9442 · Cited by 50
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2
Warner, T. D., Vojnovic, I., Bishop‐Bailey, D., & Mitchell, J. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-4434fje · Cited by 47
Straube, A. M., Aicher, B., Fiebich, B. L., & Haag, G. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-43 · Cited by 47
Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors
Karcher, S. C., & Laufer, S. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789007363 · Cited by 46
Exploring the Chemical Space of Multitarget Ligands Using Aligned Self-Organizing Maps
Achenbach, J., Klingler, F., Blöcher, R., Moser, D. M., Häfner, A., Rödl, C. B., Kretschmer, S. B. M., Krüger, B., Löhr, F., Stark, H., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4002562 · Cited by 38
Designed multiple ligands in metabolic disease research: from concept to platform
Gattrell, W. T., Johnstone, C., Patel, S., Smith, C. S., Scheel, A. A., & Schindler, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.02.006 · Cited by 25
Fishing for neuroactive compounds
Jenkins, J. L., & Urbán, L. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.320 · Cited by 14
Reconsidering the drug discovery pipeline for designed multitarget drugs
Proschak, E. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.08.019 · Cited by 7
Research works printed but not linked: 9
- Jund, 2012, Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis, Rhinology, 50, 417, 10.4193/Rhino.12.015 · doi:10.4193/rhino.12.015
- Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res., 21, 2895
- Sharma, 2001, Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels, Clin. Cancer Res., 7, 1452
- Brune, 1977, Biodistribution of salicylates: a clue to the understanding of some effects and side effects, Agents Actions Suppl., 2, 163
- Fang, 2003, Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines, Cancer Res., 63, 7563
- Naasani, 2003, Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo, Cancer Res., 63, 824
- Holmes-McNary, 2000, Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase, Cancer Res., 60, 3477
- Hope, 2008, Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention, Mol. Nutr. Food Res., 52, 52
- Gulati, 2006, The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K–Akt/PKB pathway, Anticancer Res., 26, 1177
Cited by
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Curcumin, Inflammation, and Chronic Diseases: How Are They Linked?
He, Y., Yue, Y., Zheng, X., Zhang, K., Chen, S., & Du, Z. (2015) · Molecules · doi:10.3390/molecules20059183 · Cited by 608
Talevi, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00205 · Cited by 381
Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Ivasiv, V., Albertini, C., Gonçalves, A. E., Rossi, M., & Bolognesi, M. L. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190619115735 · Cited by 375
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Zhou, J., Jiang, X., He, S., Jiang, H., Feng, F., Liu, W., Qu, W., & Sun, H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00017 · Cited by 281
Metadata
- Authors
- Koeberle, A., & Werz, O.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 19
- Issue
- 12
- Pages
- 1871-1882
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1984417882
- Cited by
- 317
- References
- 101
- FWCI
- 24.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.